Karachi: Ghani Chemical Industries Limited, a leading supplier of medical and industrial gases, has reported a robust performance for the fiscal year 2024. The company witnessed a significant rise in its gross sales, which reached Rs. 6.395 billion, up from Rs. 5.123 billion in FY 2023. This financial uptrend reflects a sustained demand for its products in a competitive market.

The firm achieved a gross profit of Rs. 1.613 billion in FY 2024, compared to Rs. 1.460 billion the previous year. The administrative, selling, and distributive expenses were managed at Rs. 491 million, maintaining a steady flow of operational costs. According to information available from the Pakistan Stock Exchange (PSX), Ghani Chemical Industries has effectively capitalized on its market positioning to enhance profitability.

Other income for the company also saw an increase, rising from Rs. 331 million in FY 2023 to Rs. 551 million in FY 2024. The profit after tax stood at Rs. 785 million, indicating a solid bottom-line growth from Rs. 508 million in the preceding year. Earnings per share (EPS) have also shown improvement, marking a value of Rs. 1.58, up from Rs. 1.06 in FY 2023.

The company’s EBITDA for the year was recorded at Rs. 1.864 billion, compared to Rs. 1.475 billion in FY 2023, demonstrating an effective control over earnings before interest, taxes, depreciation, and amortization. Ghani Chemical’s financial health is indicative of its strategic operations and financial prudence in a dynamic economic environment.